Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

President, CEO & Chairman, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Jan 9, 2024
Net Buying
Open-Market Buys
$119K
Open-Market Sells
$0
Net Open-Market Flow
$119K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2024Buy(P)50K$2.38$119K2.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-002464) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML